Around the Net

Sanofi Sues Novo Over Marketing Claims

  • Reuters, Tuesday, January 3, 2017 8 AM

Sanofi and Novo Nordisk are battling for market share in an increasingly competitive insulin field. France’s Sanofi has sued Novo over the Danish drugmaker’s marketing materials for Tresiba, alleging that they falsely claimed Sanofi’s competing products—blockbuster Lantus and follow-up Toujeo—won’t be available to many U.S. patients down the line.

Read the whole story at Reuters »

Next story loading loading..